GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Notes Receivable

4DMedical (ASX:4DX) Notes Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Notes Receivable?

4DMedical's Notes Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


4DMedical Notes Receivable Historical Data

The historical data trend for 4DMedical's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Notes Receivable Chart

4DMedical Annual Data
Trend Jun21 Jun22 Jun23
Notes Receivable
- - -

4DMedical Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial - - - - -

4DMedical Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


4DMedical Notes Receivable Related Terms

Thank you for viewing the detailed overview of 4DMedical's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


4DMedical (ASX:4DX) Business Description

Traded in Other Exchanges
Address
700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines